Literature DB >> 11083289

Serious liver disease in a patient receiving methotrexate and leflunomide.

M E Weinblatt1, J A Dixon, K R Falchuk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11083289     DOI： 10.1002/1529-0131(200011)43:11<2609::AID-ANR32>3.0.CO;2-R

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  5 in total

1.  Combination leflunomide and methotrexate in refractory rheumatoid arthritis: a biologic sparing approach.

Authors:  Bridget Hodkinson; Kingsley Ross Magomero; Mohammed Tikly
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-08-18       Impact factor: 5.346

2.  The Anti-Rheumatic Drug, Leflunomide, Induces Nephrotoxicity in Mice via Upregulation of TGFβ-Mediated p53/Smad2/3 Signaling.

Authors:  Alhanouf A Aljohani; Yasmeen S Alqarni; Maram N Alrashidi; Maha H Aljuhani; Shaimaa A Shehata; Mohamed K El-Kherbetawy; Kousalya Prabahar; Reem Alshaman; Abdullah Alattar; Ahmed M N Helaly; Hayam Ateyya; Ezzat A Ismail; Sawsan A Zaitone
Journal:  Toxics       Date:  2022-05-23

3.  Severe Bone Marrow Suppression Accompanying Pulmonary Infection and Hemorrhage of the Digestive Tract Associated with Leflunomide and Low-dose Methotrexate Combination Therapy.

Authors:  Caihong Qu; Ying Lu; Weimin Liu
Journal:  J Pharmacol Pharmacother       Date:  2017 Jan-Mar

4.  Thrombotic microangiopathy and liver toxicity due to a combination therapy of leflunomide and methotrexate: a case report.

Authors:  Rainer Ullrich Pliquett; Christoph Lübbert; Christoph Schäfer; Matthias Girndt
Journal:  J Med Case Rep       Date:  2020-02-05

5.  Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate.

Authors:  Sang-Won Lee; Hee-Jin Park; Beom Kyung Kim; Kwang-Hyub Han; Soo-Kon Lee; Seung Up Kim; Yong-Beom Park
Journal:  Arthritis Res Ther       Date:  2012-10-29       Impact factor: 5.156
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.